EFFECTIVENESS OF ADALIMUMAB COMBINATION THERAPY WITH METHOTREXATE AND NON-METHOTREXATE CSDMARDS: RESULTS FROM THE CORRONA RHEUMATOID ARTHRITIS REGISTRY

被引：0
|
作者：
Pappas, D. [1 ,2 ]
Griffith, J. [3 ]
Schlacher, C. A. [3 ]
Suboticki, J. L. [3 ]
Harrison, R. W. [2 ]
Shan, Y. [2 ]
Karki, C. [2 ]
Kremer, J. M. [4 ]
机构：
[1] Columbia Univ, New York, NY USA
[2] Corrona LLC, Southborough, MA USA
[3] AbbVie Inc, Abbott Pk, IL USA
[4] Albany Sch Med, Albany, NY USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2017-eular.1924
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0188
引用
收藏
页码：552 / 553
页数：2
相关论文
共 50 条
  • [1] EFFECTIVENESS OF LOW AND HIGH DOSE METHOTREXATE IN COMBINATION WITH ADALIMUMAB IN A REAL WORLD SETTING: RESULTS FROM THE CORRONA RHEUMATOID ARTHRITIS REGISTRY
    Pappas, D.
    Griffith, J.
    Schlacher, C. A.
    Shan, Y.
    Karki, C.
    Kremer, J. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 827 - 827
  • [2] Efficacy Of Adalimumab Plus Methotrexate Therapy In Rheumatoid Arthritis Non-Responders Receiving Methotrexate Monotherapy Or Adalimumab Combination Therapy: Results From The Optima Trial
    Smolen, Josef S.
    van Vollenhoven, Ronald F.
    Fleischmann, Roy
    Emery, Paul
    Florentinus, Stefan
    Rathmann, Suchitrita S.
    Cardoso, Anabela
    Kupper, Hartmut
    Kavanaugh, Arthur
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S999 - S1000
  • [3] EFFICACY OF ADALIMUMAB PLUS METHOTREXATE THERAPY IN RHEUMATOID ARTHRITIS NON-RESPONDERS RECEIVING METHOTREXATE MONOTHERAPY OR ADALIMUMAB COMBINATION THERAPY: RESULTS FROM THE OPTIMA TRIAL
    Smolen, Josef S.
    van Vollenhoven, Ronald F.
    Fleischmann, Roy
    Emery, Paul
    Florentinus, Stefan
    Rathmann, Suchitrita S.
    Cardoso, Anabela
    Kupper, Hartmut
    Kavanaugh, Arthur
    RHEUMATOLOGY, 2014, 53 : 89 - 89
  • [4] Methotrexate Discontinuation and Dose Decreases After Therapy With Tocilizumab: Results From the Corrona Rheumatoid Arthritis Registry
    Dimitrios A. Pappas
    Taylor Blachley
    Steve Zlotnick
    Jennie Best
    Kelechi Emeanuru
    Joel M. Kremer
    Rheumatology and Therapy, 2020, 7 : 357 - 369
  • [5] METHOTREXATE DISCONTINUATION AND DOSE DECREASES AFTER THERAPY WITH TOCILIZUMAB: RESULTS FROM THE CORRONA RHEUMATOID ARTHRITIS REGISTRY
    Pappas, Dimitrios A.
    Blachley, Taylor
    Zlotnick, Steve
    Best, Jennie H.
    Emeanuru, Kelechi
    Kremer, Joel
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1150 - 1150
  • [6] Methotrexate Discontinuation and Dose Decreases After Therapy With Tocilizumab: Results From the Corrona Rheumatoid Arthritis Registry
    Pappas, Dimitrios A.
    Blachley, Taylor
    Zlotnick, Steve
    Best, Jennie
    Emeanuru, Kelechi
    Kremer, Joel M.
    RHEUMATOLOGY AND THERAPY, 2020, 7 (02) : 357 - 369
  • [7] Methotrexate Discontinuation and Dose Decreases After Therapy with Tocilizumab: Results from the Corrona Rheumatoid Arthritis Registry
    Pappas, Dimitrios
    Blachley, Taylor
    Zlotnick, Steve
    Best, Jennie
    Emeanuru, Kelechi
    Kremer, Joel
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [8] ROLE OF METHOTREXATE AS COMBINATION THERAPY WITH ADALIMUMAB AND ETANERCEPT IN RHEUMATOID ARTHRITIS: RETROSPECTIVE ANALYSIS FROM A LOCAL REGISTRY
    Favalli, E. G.
    Becciolini, A.
    Biggioggero, M.
    Crotti, C.
    Ughi, N.
    Penatti, A. E.
    Marchesoni, A.
    Meroni, P. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 492 - 492
  • [9] EFFECTIVENESS OF ADALIMUMAB IN THE TREATMENT OF RHEUMATOID ARTHRITIS DEPENDS ON THE DOSE OF METHOTREXATE
    Ito, S.
    Oh, K.
    Unno, M.
    Kobayashi, D.
    Azuma, C.
    Abe, A.
    Otani, H.
    Ishikawa, H.
    Nakazono, K.
    Narita, I.
    Murasawa, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 437 - 437
  • [10] Combination therapy with methotrexate and hydroxychloroquine for rheumatoid arthritis increases exposure to methotrexate
    Carmichael, SJ
    Beal, J
    Day, RO
    Tett, SE
    JOURNAL OF RHEUMATOLOGY, 2002, 29 (10) : 2077 - 2083
12345